Article
Transapical valve replacement relieves mitral regurgitation
- Author:
- Daniel M. Keller, PhD
“What an absolute pleasure to be a mitral surgeon at a meeting where you’re presenting a solution for something that we find incredibly...
News

Short aspirin therapy noninferior to DAPT for 1 year after PCI for ACS
- Author:
- Daniel M. Keller, PhD
“This study provides evidence that stopping aspirin within 1 month after implantation of drug-eluting stents for ticagrelor monotherapy is a...
News

Drug-coated balloon beats conventional angioplasty for high-risk patients with in-stent restenosis
- Author:
- Daniel M. Keller, PhD
This device is a U.S. FDA–designated breakthrough device, “and this pivotal trial will be the primary evidence used to support FDA approval.”
News
Drug-eluting resorbable scaffold beats angioplasty for infrapopliteal artery disease
- Author:
- Daniel M. Keller, PhD
“If this technology is approved by the FDA, it will provide a new option for our patients with very difficult-to-treat disease, which will provide...
News
Trilogy TAVR safe, effective in aortic regurgitation
- Author:
- Daniel M. Keller, PhD
One-year mortality rate of 7.8% reported.
News
Surprisingly more nonsustained VT shown in HCM using extended ECG monitoring
- Author:
- Daniel M. Keller, PhD
Nonsustained ventricular tachycardia, an important arrhythmia used every day in clinical practice to make decisions, is “much, much more prevalent...
News

Statins tied to lower stroke risk in atrial fibrillation
- Author:
- Daniel M. Keller, PhD
Initiation of statins soon after diagnosis of AFib is associated with lower risk of ischemic and hemorrhagic strokes; longer-term use is tied to...
News
Double antiglutamatergic therapy is ‘promising’ for super-refractory status epilepticus
- Author:
- Daniel M. Keller, PhD
The novelty of the new treatment approach is the duration of therapy as well as the dual antiglutamate drugs.
News

Is genetic testing valuable in the clinical management of epilepsy?
- Author:
- Daniel M. Keller, PhD
Positive findings from genetic testing helped guide clinical management in 50% of cases and improved patient outcomes in 75%.
News
A safer way to use Botox to treat challenging dystonia type?
- Author:
- Daniel M. Keller, PhD
A critical anatomical variation is still unrecognized by most clinicians performing botulinum toxin injections for oromandibular dystonia.
News
Worsening motor function tied to post COVID syndrome in Parkinson’s disease
- Author:
- Daniel M. Keller, PhD
About half of the study participants with Parkinson’s disease who developed post–COVID-19 syndrome experienced worsening motor symptoms and needed...
News

Novel drug effective for essential tremor, but with significant side effects
- Author:
- Daniel M. Keller, PhD
Patients receiving the drug saw significant reduction in upper-limb tremors, but adverse events led many to discontinue treatment.
News

Apple devices identify early Parkinson’s disease
- Author:
- Daniel M. Keller, PhD
Study results show clear differences in a finger-tapping task in the Parkinson’s disease versus control group.
News
Surge in new-onset tics in adults tied to COVID-19 stress
- Author:
- Daniel M. Keller, PhD
“All patients, including those with organic tic disorders, had a history of anxiety and also reported worsening anxiety in the setting of the...
News

Sublingual film well tolerated for Parkinson ‘off’ episodes
- Author:
- Daniel M. Keller, PhD
While using the sublingual apomorphine film, the majority of patients did not have dose-limiting nausea or vomiting.